Polypathology and Autonomy Loss
Conditions
Brief summary
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment.. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light nighttime sleep of residents.
Detailed description
Alzheimer's disease and related syndromes (AD) is a disease affecting memory but also the relationship with the environment and empower people. Patients with AD present in 90% of cases of behavioral disorders and of these behavioral disorders include agitation, apathy but also sleep disorders by circadian rhythm impairment. In 2014, the Cochrane published a systematic review of the literature over the last 20 years concerning the use of light therapy in patients with a AD. No study has shown proven efficacy on the behavior of patients with AD. The main objective of the study was to assess the influence of environmental light therapy (from 5 a.m to 10 p.m) on nighttime sleep of residents. Secondary objectives were the study of sleep time on the day, anxiety by the COVI scale and behavioral disorders by the NPI scale.
Interventions
DEVICELight therapy
14-days exposure with an innovative ambient light
Sponsors
Centre Hospitalier Universitaire de Nice
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* EHPAD residents at Les Pastoureaux Valenton having moderate to severe MASA * More than 60 years * Presenting motor behavioral disorders and / or anxiety and / or restlessness and / or insomnia . * No underlying acute medical problems including no delirium
Exclusion criteria
* Residents refusing to lend to experimentation * Resident who are not matching with the inclusion criteria * total acquired or congenital blindness * bedridden patient ( loss of physical autonomy) * Entry to the residence less than 15 days before the start of the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep duration between 10 p.m to 5 a.m | 14 days |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety by the COVI scale | 14 days |
| Sleep duration by day | 14 days |
| Number of awake between 10 p.m to 5 a.m | 14 days |
| Behavioral disorders by the NPI scale | 14 days |
Countries
France
Outcome results
None listed